By Porter Anderson, Editor-in-Chief | @Porter_Anderson
Three No. 1 Journals in the Lippincott PortfolioIn academic, scholarly, and research journals, as Publishing Perspectives readers know, the “impact factor” is a key token of performance, expressed through the volumes of citations that might accrue to a given journal or portfolio of them. Publishers in the field of course promote good ratings from these criteria as a means of gaining visibility for their journals and attracting research writers who look for influential publications in which to release their reports.
Clarivate’s Journal Citation Reports thus becomes the token of the realm, releasing its 2023 report with coverage of what it says are 21,522 journals in 112 countries and 254 research categories.
Wolters Kluwer, based in Alphen aan den Rijn, reports that Clarivate’s evaluation this year included 387 of its journals, with slightly more than half of those (52 percent) getting a stronger ranking than in 2022. The company’s main point of pride in its media messaging, however, has to do with three medical research journals from the Lippincott portfolio.
That group of journals is focused on medicine, nursing, and allied health research. Three of those Lippincott publications came in at No. 1 in their respective areas:
Brogan: ‘A Return to Normal’
Jennifer Brogan is the vice-president of international journal publishing and society “solutions,” health learning, and research and practice at Wolters Kluwer.
In a prepared statement on the news of these journals’ ratings, Brogan is quoted as saying, “Over the past few years, we’ve seen a tremendous amount of disruption and change when it comes to the JIF calculations [Clarivate’s Journal Impact Factor evaluation], starting in 2020 with the introduction of early access and followed by inflated results from the surge of research during the COVID-19 pandemic.
“This year’s rankings indicate a return to normal and, moving forward, the numbers will show a truer year-over-year reflection of the academic research landscape.”
In spite of what Brogan’s team describes as a “recent drop-off in overall output across scientific publishing,” the company clearly sees it as a promotional asset to be able to announce that its Lippincott journals “maintained, and in some cases improved their overall rankings.” In fact, the company says that Lippincott journals were rated in Top 10 positions in fields including anesthesiology, cardiac and cardiovascular systems, obstetrics and gynecology, peripheral vascular disease, and transplantation.
Overall, the Wolters Kluwer journals highlighted by Clarivate’s 2023 assessment included first-time rankings for 164 comparatively new Lippincott journals in Clarivate’s Emerging Sources Citation Index.
In 2022, Wolters Kluwer reported annual revenues of €5.5 billion (US$6.04 billion). The company reports that it employs as many as 20,900 people internationally and has customers in 180 countries.